Transparency-Rx Applauds Passage of PBM Reform Legislation

by transparencyrx | Jan 22, 2026 | Uncategorized

Transparency‑Rx applauds the passage of the bipartisan government funding bill.  The PBM reform language included in the package is an important first step in helping to foster lower prices for patients and the business community and should promote meaningful...

Transparency-Rx Welcomes Drug Affordability Patron Network of Advanced Specialty Healthcare (NASH) as a Member

by transparencyrx | Sep 18, 2025 | Uncategorized

Transparency-Rx, a not-for-profit coalition of transparent PBMs dedicated to changing drug pricing for the better, is thrilled to announce Network of Advanced Specialty Healthcare (NASH) as its newest member. NASH joins our growing list industry experts and...

Transparency-Rx Statement on President Trump’s Executive Order on Drug Pricing

by transparencyrx | May 12, 2025 | Uncategorized

With today’s Executive Order, President Trump is right to focus attention on U.S. drug prices but in reality, prescription costs won’t meaningfully change unless we confront the real powerbrokers: offshore global middlemen and PBMs owned by insurance giants. The...

Transparency-Rx Welcomes Transformative, Clinically-Driven PBM EmpiRx Health as Newest Member

by transparencyrx | May 7, 2025 | Uncategorized

Transparency-Rx, a trusted, not-for-profit coalition dedicated to changing drug pricing for the better, is excited to announce its newest member, EmpiRx Health. They join a growing list of transparent pharmacy benefit management companies, leading industry experts,...

Transparency-Rx Statement on Federal Trade Commission Lawsuit Against Big PBMs

by transparencyrx | Sep 20, 2024 | Uncategorized

Transparency-Rx applauds the Federal Trade Commission today for bringing federal anti-trust action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations...